Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lovisa Bergwall

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Frontiers in Medicine|February 14, 2022
The Glomerulus According to the MesangiumKerstin Ebefors, Lovisa Bergwall, Jenny Nyström
Journal of the American Society of Nephrology : JASN|February 3, 2023
Podocyte Geranylgeranyl Transferase Type-I Is Essential for Maintenance of the Glomerular Filtration BarrierRoberto Boi, Lovisa Bergwall, Kerstin Ebefors, et al.
American Journal of Physiology. Renal Physiology|February 19, 2016
Melanocortin 1 receptor agonist protects podocytes through catalase and RhoA activationJohannes Elvin, Lisa Buvall, Annika Lindskog Jonsson, et al.
Scientific Reports|October 26, 2018
Amplification of the Melanocortin-1 Receptor in Nephrotic Syndrome Identifies a Target for Podocyte Cytoskeleton StabilizationLovisa Bergwall, Hanna Wallentin, Johannes Elvin, et al.
Oncotarget|December 7, 2017
Orellanine specifically targets renal clear cell carcinomaLisa Buvall, Heidi Hedman, Alina Khramova, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Frontiers in Medicine|February 14, 2022
The Glomerulus According to the MesangiumKerstin Ebefors, Lovisa Bergwall, Jenny Nyström
Journal of the American Society of Nephrology : JASN|February 3, 2023
Podocyte Geranylgeranyl Transferase Type-I Is Essential for Maintenance of the Glomerular Filtration BarrierRoberto Boi, Lovisa Bergwall, Kerstin Ebefors, et al.
American Journal of Physiology. Renal Physiology|February 19, 2016
Melanocortin 1 receptor agonist protects podocytes through catalase and RhoA activationJohannes Elvin, Lisa Buvall, Annika Lindskog Jonsson, et al.
Scientific Reports|October 26, 2018
Amplification of the Melanocortin-1 Receptor in Nephrotic Syndrome Identifies a Target for Podocyte Cytoskeleton StabilizationLovisa Bergwall, Hanna Wallentin, Johannes Elvin, et al.
Oncotarget|December 7, 2017
Orellanine specifically targets renal clear cell carcinomaLisa Buvall, Heidi Hedman, Alina Khramova, et al.
Pageof 1